Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs Flux Power Holdings Inc (FLUX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alnylam Pharmaceuticals, Inc. vs Flux Power Holdings Inc — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $227.23 (market cap $29.97B), while Flux Power Holdings Inc trades at $0.59 (market cap $12.18M). The key difference: Alnylam Pharmaceuticals, Inc. is far larger — about 2460.6× Flux Power Holdings Inc's market cap. Which is the better fit depends on your goals.
| ALNY | FLUX | |
|---|---|---|
Market Cap | $29.97B | $12.18M |
Sector | Health | Utilities |
52-Week High | $491.22 | $6.66 |
52-Week Low | $205.48 | $0.51 |
Enterprise Value | $27.93B | $18.35M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →About Flux Power Holdings Inc
Flux Power designs and manufactures lithium-ion battery packs for industrial vehicles. Its sustainable energy solutions power material handling equipment like forklifts and airport ground support vehicles.
Read more on FLUX →
